Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device could make hysterectomy safer and faster

NCT ID NCT07226375

First seen Nov 10, 2025 · Last updated Jun 22, 2026 · Updated 31 times

Summary

This study compares a new endoscopic tissue cutting device to a traditional scalpel for removing large uteri (500 grams or more) after laparoscopic hysterectomy. The device is designed to cut and remove tissue through small incisions more quickly and safely, reducing the risk of spreading potentially cancerous cells. Researchers will measure how long it takes to remove the uterus and check for complications, as well as effects on sexual function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LAPAROSCOPIC HYSTERECTOMY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Izmir Bakircay University

    RECRUITING

    Izmir, 35665, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Endoscopic tissue cutting and abdominal extraction device

What this could lead to

If successful, this device could make laparoscopic hysterectomy faster and safer by reducing the risk of tissue spreading and shortening surgery time.

What could go wrong

This is a small, early-stage trial with only 84 participants, so results may not apply to all patients. The device is new and its long-term safety and effectiveness are not yet proven.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.